Applied Materials is a world-wide largest Semiconductor and Display equipment manufacturer.
Apeximmune Therapeutics seeks to harness the power of the immune system to treat and cure cancer. We discover and pioneer innovative therapeutic antibodies against novel targets to modulate immune cell activity and elicit durable efficacy in cancer. Apeximmune’s target discovery platform combines bioinformatics with biological assays to enable identification of novel immune modulating targets. Currently, antibodies for three immuno-oncology target programs in the pre-clinical stage are being actively developed with the goal of reaching IND status within 18 months.
BioLegend develops world-class, cutting-edge antibodies and reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, CA. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value, along with superior customer service and technical support.
Our product expertise covers a diverse set of research areas including Immunology, Neuroscience, Cancer, Stem cells, and Cell Biology. BioLegend's reagents are supported by superior customer service and a quality management system that is certified for ISO 13485:2016. Our aggressive product development program, through technology licensing, collaborations, and internal hybridoma development, produces strategic reagents for use in a variety of applications including:
Flow cytometry and mass cytometry
ELISA and ELISPOT
Immunoprecipitation and ChIP
Western blotting
Immunofluorescence microscopy
Immunohistochemistry
In vitro or in vivo functional assays.
Quantitative Multiplexing
BioLegend offers the broadest selection of fluorochrome conjugates for multi-color flow cytometry. With an experienced biochemistry team, BioLegend is well positioned to offer a wide range of custom conjugation services to meet our customers' specific needs.
Our commitment to the research community is reflected in generous sponsorships of societies and meetings world-wide, our monthly travel award for junior investigators, and excellent bulk pricing. With iPhone/iPad apps, web tools, beautifully detailed posters, and new reagents, we look forward to bringing more creative innovation to make your research legendary.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. Genentech became a member of the Roche Group in March of 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech's South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development operates as an independent center within Roche.
Kyocera International Inc. is a subsidiary of Kyocera Corporation. Kyocera International Inc. conducts business in multiple areas (Semiconductor Components, Communication Equipment Group, Fine Ceramics Group, Optical Division, Consumer Product Division, Display Division, Automotive Components). The division which will participate in LEAP activity has been developing mmWave phased-array antenna for past 30 years. The division is actively developing RFIC, microwave package, phased-array antenna for 5G cellular and Satellite market.
LIGHTEL is an advanced technology company located in the Greater Seattle to service the Fiber Optics & Photonics industries worldwide. The new focus is to develop Hi-power (KW) technologies for
Fiber Laser applications to serve the Industry 4.0., IMS (Intelligent Manufacturing System) and
Autonomous Vehicles.
NVIDIA’s invention of the GPU sparked the PC gaming market. The company’s pioneering work in accelerated computing—a supercharged form of computing at the intersection of computer graphics, high performance computing and AI—is reshaping trillion-dollar industries, such as transportation, healthcare and manufacturing, and fueling the growth of many others.
PARTNERS AND COLLABORATORS
Omega Optics, Inc. is a leading company started in Austin, Texas in 2001. Since its initiation, Omega Optics has been actively involved in optical communications/sensing field where arrays of products have been developed from internal R&D and SBIR/STTR efforts. Technologies including portable bio-sensing, polymer based planar light wave circuit for EM-wave sensing, chemical and biological sensing , and nanophotonics for integrated photonic circuits, are core technologies. Omega Optics, with its vast experience in SBIR/STTR programs, is in a vantage position to pursue this aggressive commercialization strategy. Omega’s scientists and engineers have research project experience with partners and sponsors such as General Electric, Cray Research, Honeywell, 3M, Dell, Lightpath, Boeing, Physical Optics Corp., Novex Corp., Lambda Physik USA. The management team has a commercialization track record of raising $18 million venture capital investment SBIR phase II matching funds in 2000 from Intel venture, KLM venture which was later acquired by Finisar, a publicly traded company, in 2001.
Founded in 2018, PETcoil was formed by a group of imaging scientists, engineers, and radiologists aspired to improve healthcare by creating novel medical imaging technology and bringing it to millions of patients around the globe. Our team has its roots at Stanford University, where our founders created their first-ever radiofrequency-penetrable PET insert system for simultaneous PET and MRI imaging.
Our vision is to make multi-modality medical imaging accessible to every patient. Our mission is to create affordable, high-performance molecular imaging systems to drive early and accurate diagnosis of diseases.
(Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines.
Taboola helps people find relevant content online, matching them with news stories, articles, blogs, videos, apps, products and other content they’re likely to want to explore.
How do we know what they’ll like? Using machine-learning algorithms, our technology analyzes hundreds of signals to capture exactly what kind of content is most likely to engage each individual. We do that more than 450 billion times a month for more than one billion unique users.
Since we opened our doors in 2006, we have grown to become the leading discovery platform on the open web, serving a combination of the world’s best brands and the most respected global publishers.
Taboola is headquartered in New York City with local offices in Los Angeles, London, Tel Aviv, New Delhi, Bangkok, São Paulo, Beijing, Shanghai, Istanbul, Seoul, Sydney and Tokyo.
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry.
Tubis Technology Inc. has been developing mmWave phased-array antenna for 5G cellular and Satellite market for the past 6 years. The area of focus and expertise is Semiconductor Design – Advanced CMOS and GaAs, Packaging Technology – antenna in package and silicon in package, RF systems technology – RF IC design, phased-array technology, beam forming
By designing wearable devices in new ways, Wearifi is a technology company seeking to create epidermal electronics with all of the performance of the current state of the art at a fraction of the size. Our mission is to devise the next generation of electronic solutions – integrated, invisible when you want them to be, and battery-free – to personal healthcare that promote positive feedback between cognitive science and precision medicine.
Wearifi has partnered with multiple Fortune 500 companies, the Department of Health and Human Services, and leading research hospitals to drive personalized healthcare management with wearable electronic gadgets. The core technology represents not only the outcome of research efforts from Querrey Simpson Institute for Bioelectronics at Northwestern University but continuous interactions with the research/clinical teams to develop engineering solutions that are capable of non-invasively skin health monitoring, motion envelope visualization, haptic feedback for VR/AR and prosthetic applications, in-real time. At Wearifi, you’ll have an opportunity to work in a collaborative environment that leads to academic publications and technology innovations, so together we can engineer the future of smart healthcare.
Applied Materials is a world-wide largest Semiconductor and Display equipment manufacturer.
Apeximmune Therapeutics seeks to harness the power of the immune system to treat and cure cancer. We discover and pioneer innovative therapeutic antibodies against novel targets to modulate immune cell activity and elicit durable efficacy in cancer. Apeximmune’s target discovery platform combines bioinformatics with biological assays to enable identification of novel immune modulating targets. Currently, antibodies for three immuno-oncology target programs in the pre-clinical stage are being actively developed with the goal of reaching IND status within 18 months.
BioLegend develops world-class, cutting-edge antibodies and reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, CA. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value, along with superior customer service and technical support.
Our product expertise covers a diverse set of research areas including Immunology, Neuroscience, Cancer, Stem cells, and Cell Biology. BioLegend's reagents are supported by superior customer service and a quality management system that is certified for ISO 13485:2016. Our aggressive product development program, through technology licensing, collaborations, and internal hybridoma development, produces strategic reagents for use in a variety of applications including:
Flow cytometry and mass cytometry
ELISA and ELISPOT
Immunoprecipitation and ChIP
Western blotting
Immunofluorescence microscopy
Immunohistochemistry
In vitro or in vivo functional assays.
Quantitative Multiplexing
BioLegend offers the broadest selection of fluorochrome conjugates for multi-color flow cytometry. With an experienced biochemistry team, BioLegend is well positioned to offer a wide range of custom conjugation services to meet our customers' specific needs.
Our commitment to the research community is reflected in generous sponsorships of societies and meetings world-wide, our monthly travel award for junior investigators, and excellent bulk pricing. With iPhone/iPad apps, web tools, beautifully detailed posters, and new reagents, we look forward to bringing more creative innovation to make your research legendary.
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. Genentech became a member of the Roche Group in March of 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech's South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development operates as an independent center within Roche.
Kyocera International Inc. is a subsidiary of Kyocera Corporation. Kyocera International Inc. conducts business in multiple areas (Semiconductor Components, Communication Equipment Group, Fine Ceramics Group, Optical Division, Consumer Product Division, Display Division, Automotive Components). The division which will participate in LEAP activity has been developing mmWave phased-array antenna for past 30 years. The division is actively developing RFIC, microwave package, phased-array antenna for 5G cellular and Satellite market.
LIGHTEL is an advanced technology company located in the Greater Seattle to service the Fiber Optics & Photonics industries worldwide. The new focus is to develop Hi-power (KW) technologies for
Fiber Laser applications to serve the Industry 4.0., IMS (Intelligent Manufacturing System) and
Autonomous Vehicles.
NVIDIA’s invention of the GPU sparked the PC gaming market. The company’s pioneering work in accelerated computing—a supercharged form of computing at the intersection of computer graphics, high performance computing and AI—is reshaping trillion-dollar industries, such as transportation, healthcare and manufacturing, and fueling the growth of many others.
PARTNERS AND COLLABORATORS
Omega Optics, Inc. is a leading company started in Austin, Texas in 2001. Since its initiation, Omega Optics has been actively involved in optical communications/sensing field where arrays of products have been developed from internal R&D and SBIR/STTR efforts. Technologies including portable bio-sensing, polymer based planar light wave circuit for EM-wave sensing, chemical and biological sensing , and nanophotonics for integrated photonic circuits, are core technologies. Omega Optics, with its vast experience in SBIR/STTR programs, is in a vantage position to pursue this aggressive commercialization strategy. Omega’s scientists and engineers have research project experience with partners and sponsors such as General Electric, Cray Research, Honeywell, 3M, Dell, Lightpath, Boeing, Physical Optics Corp., Novex Corp., Lambda Physik USA. The management team has a commercialization track record of raising $18 million venture capital investment SBIR phase II matching funds in 2000 from Intel venture, KLM venture which was later acquired by Finisar, a publicly traded company, in 2001.
Founded in 2018, PETcoil was formed by a group of imaging scientists, engineers, and radiologists aspired to improve healthcare by creating novel medical imaging technology and bringing it to millions of patients around the globe. Our team has its roots at Stanford University, where our founders created their first-ever radiofrequency-penetrable PET insert system for simultaneous PET and MRI imaging.
Our vision is to make multi-modality medical imaging accessible to every patient. Our mission is to create affordable, high-performance molecular imaging systems to drive early and accurate diagnosis of diseases.
(Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines.
Taboola helps people find relevant content online, matching them with news stories, articles, blogs, videos, apps, products and other content they’re likely to want to explore.
How do we know what they’ll like? Using machine-learning algorithms, our technology analyzes hundreds of signals to capture exactly what kind of content is most likely to engage each individual. We do that more than 450 billion times a month for more than one billion unique users.
Since we opened our doors in 2006, we have grown to become the leading discovery platform on the open web, serving a combination of the world’s best brands and the most respected global publishers.
Taboola is headquartered in New York City with local offices in Los Angeles, London, Tel Aviv, New Delhi, Bangkok, São Paulo, Beijing, Shanghai, Istanbul, Seoul, Sydney and Tokyo.
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry.
Tubis Technology Inc. has been developing mmWave phased-array antenna for 5G cellular and Satellite market for the past 6 years. The area of focus and expertise is Semiconductor Design – Advanced CMOS and GaAs, Packaging Technology – antenna in package and silicon in package, RF systems technology – RF IC design, phased-array technology, beam forming
By designing wearable devices in new ways, Wearifi is a technology company seeking to create epidermal electronics with all of the performance of the current state of the art at a fraction of the size. Our mission is to devise the next generation of electronic solutions – integrated, invisible when you want them to be, and battery-free – to personal healthcare that promote positive feedback between cognitive science and precision medicine.
Wearifi has partnered with multiple Fortune 500 companies, the Department of Health and Human Services, and leading research hospitals to drive personalized healthcare management with wearable electronic gadgets. The core technology represents not only the outcome of research efforts from Querrey Simpson Institute for Bioelectronics at Northwestern University but continuous interactions with the research/clinical teams to develop engineering solutions that are capable of non-invasively skin health monitoring, motion envelope visualization, haptic feedback for VR/AR and prosthetic applications, in-real time. At Wearifi, you’ll have an opportunity to work in a collaborative environment that leads to academic publications and technology innovations, so together we can engineer the future of smart healthcare.
須有等同托福 iBT(Internet-Based TOEFL)測驗成績 89 分以上的能力。獲選學者在出發前須提供托福成績證明。博士學位在英語國家獲得者不在此限。
【甄選資訊】
LEAP@BERKELEY與加州大學柏克萊分校工學院合作,本計畫每年將選送4名具創新創業企圖心之人才赴加州大學柏克萊分校工學院,包含以下申請類別:
A) 2名「台灣-柏克萊醫療器材產品設計之人才培訓計畫」(Berkeley-Taiwan Biomedical Fellowship Program;簡稱BTB),赴加州大學柏克萊分校工學院接受為期一年之的高階醫療器材設計及商業化實務訓練。歡迎有意願投入醫療器材設計領域者,踴躍報名申請。
B) 2名具產業技術研發能力以及創新創業企圖心之人才赴加州大學柏克萊分校工學院,接受為期一年之研習技術商業化知識與實務訓練。
加州大學柏克萊分校會依入選者之領域專長背景分類,並安排工學院內相關領域實驗室資源研習及教授專家指導。(請參考加州大學柏克萊分校工學院官網:http://engineering.berkeley.edu/)
英文能力證明:提供英文能力測驗成績證明尤佳(TOEFL iBT或IELTS)。
甄選方式
1.【書面初審】
就申請人所上傳之書面申請資料,由評選委員會進行書審,評選出合格申請者。
2.【複選面試】
由柏克萊大學評審委員會決定進入複選面試人員,再經由評選委員會以英文進行面試,從中選出符合受訓資格之人員前往美國加州大學柏克萊分校接受培訓。
【甄選資訊 】
LEAP@Duke 與杜克大學合作,本計畫將選送 2 名具產業技術研發能力以及創新創業企圖心之博士級人才,接受為期一年人工智慧 (AI) 於健康醫療領域之深度研究。
The focus of the LEAP@Duke program is bridging mathematics, statistics and medicine for biomedical signal processing and providing a concrete artificial intelligence solution for one specific problem in healthcare. The candidates are encouraged to bring their own clinical problem, database, preliminary research result, or even prototype. They will stay in Duke University for one year. In addition to finding team members to implement the solution, the candidates are encouraged to participate in the research, the collaboration in hospitals and industrial activities in the Research Triangle.
申請資格:
Applicants should have either a medical degree, or a PhD degree in computer science, electrical engineering, statistics or applied mathematics.
1. 申請人須有醫療資訊或程式語言設計相關背景知識,具備生理時間序列訊號分析經驗者尤佳。
2. 申請人具有(1)應用數學、統計、電機、資工、醫工所和醫療相關科系 (如復健科系)博士學位(Ph.D)、等同學歷或博士班將畢業。
或(2)各醫院醫師MD,對各式生理監視系統有強烈興趣者尤佳。
培訓內容:
1. 內容與比例
(1) 定期與LEAP@Duke教授討論且執行智慧生理監視系統之專案開發(60%)。
(2) 參與創投及創業相關活動(20%)。
(3) 參與Duke合作實驗室的weekly seminar、Lab group meeting與校內學術相關活動(20%)。
2. 期間有機會參與美國其他大學 (如耶魯大學、普林斯頓大學與史丹佛大學)的學術交流活動。
3. 學員完成一年培訓後,預期做出prototype,例如加護病房的智慧精準預測系統,手術房的麻醉血行動力學精準監視系統,居家睡眠精準調控系統,及其他(鼓勵學員自帶題目)。
【甄選資訊】
一、簡介
為使台灣於全球數位醫療產業能具備領先地位,LEAP@MGH計畫每年選派2-3位人才赴美國波士頓-麻州總醫院電腦科學實驗室(MGH, Laboratory of Computer Science),接受為期一年的智慧醫療及商業化實務培訓。大波士頓地區擁有世界知名學府和醫學中心,結合高科技核心和密集的醫學研究能量,培育學員參與當地新創事業加速器、商業創業競賽、Hackathon及向創投學習機會,發展智慧醫療創新技術並尋求創業機會。
培訓內容及比例:參與哈佛醫學院及MIT史隆管理學院之生醫資訊及創業發展課程(20%)、於麻州總醫院電腦科學實驗室(MGH, LCS)執行智慧醫療及臨床資訊之專案開發(60%)、參與創投及創業相關活動(20%)。
二、申請資格
1. 學經歷:申請人須有醫療資訊或程式語言設計相關背景知識或智慧醫療領域專長與創業經驗,具備博士學位Ph.D., M.D.或等同學歷尤佳。
2. 英文能力證明:須提供英文能力測驗成績證明。
三、報名時間
四、甄選方式
1. 【書面資料初選】
以申請人所繳交之申請資料進行資格審核,由評選委員初步評選出合格申請者進入複選。
2. 【複選面試】
進入複選者,由哈佛大學/麻州總醫院之評選委員進行英文面試,從中選出符合受訓資格之人員前往美國波士頓接受為期一年的培訓。
【甄選資訊 】
為促進「健康數據分析 (Health Data Analytics)」領域之研究,本計畫與麻省理工學院 (MIT) 醫學工程與科學研究所 (Institute for Medical Engineering and Science , IMES) 合作展開博士後人員交流計畫,將選送數名國內優秀之博士後研究學者赴IMES為期一年,參與醫療資訊分析領域的研究計畫,合作實驗室包括運算生理實驗室 (Laboratory for Computational Physiology)、整合神經監測及重症醫學資訊實驗室 (Integrative Neuromonitoring and Critical Care Informatics Group)、臨床機器學習實驗室 (Clinical Machine Learning Group) 等。
IMES成立於2012年,為MIT所屬專責先進醫療器材與產品的創新研究與開發研究所,其任務之一為提升美國醫療保健的價值,並試圖為愈趨高漲的醫療成本解套,為美國少數在第一線解決臨床醫學所面臨各式挑戰的醫學研究機構。IMES在工程、科學、臨床醫學等領域結合了研究工作與教育推廣,藉由與當地醫療院所的密切合作與利用創新醫療科學技術,以促進人類的健康福祉。
申請資格
(1). Applicants have Ph.D. degree or M.D. degree with significant data analytics, statistical, or programming experience.
(2). Candidates have training or experience in Medicine and/or Computer Science/Engineering is preferred.
申請方式
Step 1: Submit a complete application online.
The application consists of:
-Personal statement of purpose (maximum 2 pages), including an indication of --preferred host laboratory (may option more than one lab, but must have a supporting argument for each).
-Curriculum Vitae, including links to relevant research papers and/or theses.
-Academic transcript.
-Proof of doctoral degree (if not part of the transcript)
-Two or more Letters of Reference.
Step 2: IMES faculty and staff will review applicants and select candidates for personal interviews. Candidates will be assessed based on the following criteria:
-Evidence of academic excellence (courses, grades)
-Evidence of research productivity
-Reference letters
-The applicant’s statement of purpose
-Evidence of proficiency in spoken and written English
-Synergy between the training and goals of the applicant and the research priorities of the IMES laboratory
【甄選資訊】
每梯次LEAP@STANFORD將甄選4名赴史丹佛大學化學工程學系進行科技創新發展訓練。入選的LEAP@STANFORD學者在培訓期間,將透過實務訓練,及不同領域的跨界學習,瞭解創新價值,進而加速從理論至商品化的契機。入選的學者並會依據其專長、興趣及發展需求安排進入化工系內相關領域實驗室研習及接受教授專家的指導合作。
本計畫的特色為著重跨領域及跨實驗室的合作,藉以深化人脈的連結以及產學合作及創業的未來潛力,LEAP@STANFORD 學者可參與媒合的實驗室的研究工作, 史丹佛大學提供的課程與會議,定期與LEAP@STANFORD教授討論,並鼓勵加入創新創業社群活動。
一. 申請資格
1. 學經歷:(1)具有化工、醫工 材料、化學、物理 生物及相關領域之博士學位者(Ph.D.);(2)具有醫學系學位(M.D.) 且有三年以上工作經驗及可茲證明其研究專長的文件,如獲得重要創新獎項,主要專利發明人或重要期刊論文之主要作者等;或(3)具有化工、醫工、材料、化學、物理、生物及相關領域之碩士學位者,且有三年以上工作經驗及可茲證明其研究專長的文件,如獲得重要創新獎項,主要專利發明人或重要期刊論文之主要作者等。
2. 英語能力證明:須有等同托福iBT (Internet-Based TOEFL) 測驗成績89分以上的能力。獲選學者在出發前須提供托福成績證明。博士學位在英語國家獲得者不在此限。
二. 評選標準與過程
1. 【書面初審】
就申請人所上傳之書面申請資料,由評選委員進行書面資格審核,評選出合格申請者。所附資料應包括完整履歷及簡要說明申請本計畫預期達成目標與未來生涯規劃的相關性。
2. 【躍升培訓營】完成報名且符合徵選資格之候選學員方獲得參與本計畫辦理之躍升培訓營資格,候選學員應全程參與躍升培訓營,於活動期間建立創新創業人脈、學習創業規劃、溝通及簡報技巧,並與企業先進交流互動。確切時程依本計畫辦公室公告為主。
3.【複選面試】
初審通過人員皆須依規定繳交複審資料予史丹佛大學進行書審複審,由評審委員決定進入複選面試人員,再經由評選委員會進行英文面試。
主要遴選標準包括
-學術專業表現(scholarly achievements)
-轉譯研究之學習動機 (motivation for translational research)
-創新創業之高度熱誠(strong interest in entrepreneurship)
-在跨領域與多元文化之學習能力(ability to function in a multi-disciplinary, multi-cultural environment)
-研究領域媒合度(matched interests and goals).
相關研究領域可包括奈米科學 nanoscience, 替代能源alternative energy, 表面化學surface science, 介面工程interfacial engineering, 光觸媒photocatalysis, 軟性材料soft materials, 高分子科學(實驗及理論計算) polymer science and simulation, 流變學rheology, 流體力學fluidic mechanics, 微流道學microfluidics, 有機電子organic electronics, 生物材料biomaterials, 組織工程tissue engineering, 生物力學mechanobiology, 細胞生物cell biology, 腫瘤生物學cancer biology, 幹細胞生物學stem cell biology 及其他相關應用科學。 欲申請者亦可參考化工系網頁:https://cheme.stanford.edu/research
三. 報名時間:2020/04/01~2020/04/30
【甄選資訊】
LEAP@BERKELEY與加州大學柏克萊分校工學院合作,本計畫每年將選送4名具創新創業企圖心之人才赴加州大學柏克萊分校工學院,包含以下申請類別:
A) 2名「台灣-柏克萊醫療器材產品設計之人才培訓計畫」(Berkeley-Taiwan Biomedical Fellowship Program;簡稱BTB),赴加州大學柏克萊分校工學院接受為期一年之的高階醫療器材設計及商業化實務訓練。歡迎有意願投入醫療器材設計領域者,踴躍報名申請。
B) 2名具產業技術研發能力以及創新創業企圖心之人才赴加州大學柏克萊分校工學院,接受為期一年之研習技術商業化知識與實務訓練。
加州大學柏克萊分校會依入選者之領域專長背景分類,並安排工學院內相關領域實驗室資源研習及教授專家指導。(請參考加州大學柏克萊分校工學院官網:http://engineering.berkeley.edu/)
英文能力證明:提供英文能力測驗成績證明尤佳(TOEFL iBT或IELTS)。
甄選方式
1.【書面初審】
就申請人所上傳之書面申請資料,由評選委員會進行書審,評選出合格申請者。
2.【複選面試】
由柏克萊大學評審委員會決定進入複選面試人員,再經由評選委員會以英文進行面試,從中選出符合受訓資格之人員前往美國加州大學柏克萊分校接受培訓。
【甄選資訊 】
LEAP@Duke 與杜克大學合作,本計畫將選送 2 名具產業技術研發能力以及創新創業企圖心之博士級人才,接受為期一年人工智慧 (AI) 於健康醫療領域之深度研究。
The focus of the LEAP@Duke program is bridging mathematics, statistics and medicine for biomedical signal processing and providing a concrete artificial intelligence solution for one specific problem in healthcare. The candidates are encouraged to bring their own clinical problem, database, preliminary research result, or even prototype. They will stay in Duke University for one year. In addition to finding team members to implement the solution, the candidates are encouraged to participate in the research, the collaboration in hospitals and industrial activities in the Research Triangle.
申請資格:
Applicants should have either a medical degree, or a PhD degree in computer science, electrical engineering, statistics or applied mathematics.
1. 申請人須有醫療資訊或程式語言設計相關背景知識,具備生理時間序列訊號分析經驗者尤佳。
2. 申請人具有(1)應用數學、統計、電機、資工、醫工所和醫療相關科系 (如復健科系)博士學位(Ph.D)、等同學歷或博士班將畢業。
或(2)各醫院醫師MD,對各式生理監視系統有強烈興趣者尤佳。
培訓內容:
1. 內容與比例
(1) 定期與LEAP@Duke教授討論且執行智慧生理監視系統之專案開發(60%)。
(2) 參與創投及創業相關活動(20%)。
(3) 參與Duke合作實驗室的weekly seminar、Lab group meeting與校內學術相關活動(20%)。
2. 期間有機會參與美國其他大學 (如耶魯大學、普林斯頓大學與史丹佛大學)的學術交流活動。
3. 學員完成一年培訓後,預期做出prototype,例如加護病房的智慧精準預測系統,手術房的麻醉血行動力學精準監視系統,居家睡眠精準調控系統,及其他(鼓勵學員自帶題目)。
【甄選資訊】
一、簡介
為使台灣於全球數位醫療產業能具備領先地位,LEAP@MGH計畫每年選派2-3位人才赴美國波士頓-麻州總醫院電腦科學實驗室(MGH, Laboratory of Computer Science),接受為期一年的智慧醫療及商業化實務培訓。大波士頓地區擁有世界知名學府和醫學中心,結合高科技核心和密集的醫學研究能量,培育學員參與當地新創事業加速器、商業創業競賽、Hackathon及向創投學習機會,發展智慧醫療創新技術並尋求創業機會。
培訓內容及比例:參與哈佛醫學院及MIT史隆管理學院之生醫資訊及創業發展課程(20%)、於麻州總醫院電腦科學實驗室(MGH, LCS)執行智慧醫療及臨床資訊之專案開發(60%)、參與創投及創業相關活動(20%)。
二、申請資格
1. 學經歷:申請人須有醫療資訊或程式語言設計相關背景知識或智慧醫療領域專長與創業經驗,具備博士學位Ph.D., M.D.或等同學歷尤佳。
2. 英文能力證明:須提供英文能力測驗成績證明。
三、報名時間
四、甄選方式
1. 【書面資料初選】
以申請人所繳交之申請資料進行資格審核,由評選委員初步評選出合格申請者進入複選。
2. 【複選面試】
進入複選者,由哈佛大學/麻州總醫院之評選委員進行英文面試,從中選出符合受訓資格之人員前往美國波士頓接受為期一年的培訓。
【甄選資訊 】
為促進「健康數據分析 (Health Data Analytics)」領域之研究,本計畫與麻省理工學院 (MIT) 醫學工程與科學研究所 (Institute for Medical Engineering and Science , IMES) 合作展開博士後人員交流計畫,將選送數名國內優秀之博士後研究學者赴IMES為期一年,參與醫療資訊分析領域的研究計畫,合作實驗室包括運算生理實驗室 (Laboratory for Computational Physiology)、整合神經監測及重症醫學資訊實驗室 (Integrative Neuromonitoring and Critical Care Informatics Group)、臨床機器學習實驗室 (Clinical Machine Learning Group) 等。
IMES成立於2012年,為MIT所屬專責先進醫療器材與產品的創新研究與開發研究所,其任務之一為提升美國醫療保健的價值,並試圖為愈趨高漲的醫療成本解套,為美國少數在第一線解決臨床醫學所面臨各式挑戰的醫學研究機構。IMES在工程、科學、臨床醫學等領域結合了研究工作與教育推廣,藉由與當地醫療院所的密切合作與利用創新醫療科學技術,以促進人類的健康福祉。
申請資格
(1). Applicants have Ph.D. degree or M.D. degree with significant data analytics, statistical, or programming experience.
(2). Candidates have training or experience in Medicine and/or Computer Science/Engineering is preferred.
申請方式
Step 1: Submit a complete application online.
The application consists of:
-Personal statement of purpose (maximum 2 pages), including an indication of --preferred host laboratory (may option more than one lab, but must have a supporting argument for each).
-Curriculum Vitae, including links to relevant research papers and/or theses.
-Academic transcript.
-Proof of doctoral degree (if not part of the transcript)
-Two or more Letters of Reference.
Step 2: IMES faculty and staff will review applicants and select candidates for personal interviews. Candidates will be assessed based on the following criteria:
-Evidence of academic excellence (courses, grades)
-Evidence of research productivity
-Reference letters
-The applicant’s statement of purpose
-Evidence of proficiency in spoken and written English
-Synergy between the training and goals of the applicant and the research priorities of the IMES laboratory
【甄選資訊】
每梯次LEAP@STANFORD將甄選4名赴史丹佛大學化學工程學系進行科技創新發展訓練。入選的LEAP@STANFORD學者在培訓期間,將透過實務訓練,及不同領域的跨界學習,瞭解創新價值,進而加速從理論至商品化的契機。入選的學者並會依據其專長、興趣及發展需求安排進入化工系內相關領域實驗室研習及接受教授專家的指導合作。
本計畫的特色為著重跨領域及跨實驗室的合作,藉以深化人脈的連結以及產學合作及創業的未來潛力,LEAP@STANFORD 學者可參與媒合的實驗室的研究工作, 史丹佛大學提供的課程與會議,定期與LEAP@STANFORD教授討論,並鼓勵加入創新創業社群活動。
一. 申請資格
1. 學經歷:(1)具有化工、醫工 材料、化學、物理 生物及相關領域之博士學位者(Ph.D.);(2)具有醫學系學位(M.D.) 且有三年以上工作經驗及可茲證明其研究專長的文件,如獲得重要創新獎項,主要專利發明人或重要期刊論文之主要作者等;或(3)具有化工、醫工、材料、化學、物理、生物及相關領域之碩士學位者,且有三年以上工作經驗及可茲證明其研究專長的文件,如獲得重要創新獎項,主要專利發明人或重要期刊論文之主要作者等。
2. 英語能力證明:須有等同托福iBT (Internet-Based TOEFL) 測驗成績89分以上的能力。獲選學者在出發前須提供托福成績證明。博士學位在英語國家獲得者不在此限。
二. 評選標準與過程
1. 【書面初審】
就申請人所上傳之書面申請資料,由評選委員進行書面資格審核,評選出合格申請者。所附資料應包括完整履歷及簡要說明申請本計畫預期達成目標與未來生涯規劃的相關性。
2. 【躍升培訓營】完成報名且符合徵選資格之候選學員方獲得參與本計畫辦理之躍升培訓營資格,候選學員應全程參與躍升培訓營,於活動期間建立創新創業人脈、學習創業規劃、溝通及簡報技巧,並與企業先進交流互動。確切時程依本計畫辦公室公告為主。
3.【複選面試】
初審通過人員皆須依規定繳交複審資料予史丹佛大學進行書審複審,由評審委員決定進入複選面試人員,再經由評選委員會進行英文面試。
主要遴選標準包括
-學術專業表現(scholarly achievements)
-轉譯研究之學習動機 (motivation for translational research)
-創新創業之高度熱誠(strong interest in entrepreneurship)
-在跨領域與多元文化之學習能力(ability to function in a multi-disciplinary, multi-cultural environment)
-研究領域媒合度(matched interests and goals).
相關研究領域可包括奈米科學 nanoscience, 替代能源alternative energy, 表面化學surface science, 介面工程interfacial engineering, 光觸媒photocatalysis, 軟性材料soft materials, 高分子科學(實驗及理論計算) polymer science and simulation, 流變學rheology, 流體力學fluidic mechanics, 微流道學microfluidics, 有機電子organic electronics, 生物材料biomaterials, 組織工程tissue engineering, 生物力學mechanobiology, 細胞生物cell biology, 腫瘤生物學cancer biology, 幹細胞生物學stem cell biology 及其他相關應用科學。 欲申請者亦可參考化工系網頁:https://cheme.stanford.edu/research
三. 報名時間:2020/04/01~2020/04/30